Pharmafile Logo

immunotherapies

VuuAI and Amiculum

VuuAI and Amiculum partner to transform content engagement in pharma

Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation platform. The collaboration is designed to optimize the deployment of...

Amiculum

- PMLiVE

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

Inizio

- PMLiVE

Enhancing Medical Education through Gamification and Innovative Technologies

One innovative approach that has gained traction in recent years is gamification—the integration of game elements such as points, leaderboards, and interactive elements into learning activities. Understanding gamification’s role in...

Impetus Digital

- PMLiVE

Almirall and Absci expand AI dermatological drug discovery partnership

The alliance has already led to the delivery of functional antibody leads against a difficult-to-drug target

- PMLiVE

NHS programme to give head and neck cancer patients fast-track access to mRNA vaccine

More than 11,000 people are diagnosed with head and neck cancers every year in England

Unlocking the future of Learning

By Potter Li and Aaron Fletcher

Amiculum

- PMLiVE

New Webinar: Supercharge Pharma Med Ed with AI

Unlock the power of AI to transform pharma medical education, training, and critical insight gathering. Discover how next-gen AI tech such as AI Avatars, enable hyper-realistic training, enhance engagement, and...

Impetus Digital

- PMLiVE

New Webinar: The AI-Driven Future of Medical Education for Pharma

Imagine MedEd that thinks, adapts, and delivers unprecedented insights. Better yet, experience if for yourself in our upcoming pharma-exclusive webinar, "Unlocking Brainpower: The AI-Driven Future of Medical Education for Pharma."...

Impetus Digital

- PMLiVE

BioNTech expands mRNA capabilities with $1.25bn CureVac acquisition

The deal will support the advancement of BioNTech’s mRNA-based cancer immunotherapies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links